News from foundation venture capital group

Mar 19, 2014, 14:10 ET

Foundation Venture Capital Group (FVCG) Adds New Senior Director

Michael A. Wiley has joined Foundation Venture Capital Group (FVCG), an affiliate of New Jersey Health Foundation, as the  Senior Director of...

Jan 31, 2014, 11:20 ET

Foundation Venture Capital Group portfolio company, Snowdon, issued patents to treat pain and advance drug discovery

Drug discovery and development company Snowdon Inc., a Foundation Venture Capital Group portfolio company, has been issued two new patents to treat...

Nov 07, 2013, 11:25 ET

Actinobac Biomed Founder Receives Two Awards For Promising New Drug

 Scott Kachlany, PhD, founder of Actinobac Biomed, Inc., has received a Thomas Edison Patent of the Year Award from the Research and...

Oct 28, 2013, 11:35 ET

Foundation Venture Capital Group Portfolio Company Identifies FRY Gene As Breast Cancer Susceptibility Suppressor

 Researchers from GeneAssess, Inc., a Foundation Venture Capital Group portfolio company, announce the publication of the genetic studies that...

Oct 03, 2013, 13:35 ET

The Michael J. Fox Foundation Funds Research to Develop Parkinson's Blood Test

 Research being performed by Durin Technologies, Inc., exploring the development of a novel blood test for Parkinson's disease was recently...

Apr 18, 2013, 13:20 ET

Foundation Venture Capital Group Invests In Company Developing Implantable Meniscus for Knee Repair

 Newly formed NovoPedics, Inc., has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its...

Jun 29, 2012, 10:35 ET

Foundation Venture Capital Group Makes Eighth Start-Up Investment

Company Developing Diagnostic Tool for More Accurate Breast Cancer Staging GeneAssess, Inc., a New Jersey-based biotechnology company,...

Jun 27, 2011, 12:45 ET

Recent Study Shows Leukothera™ Combined with Other Agents Has Enhanced Anti-Leukemia Effects

Recent findings published in the scientific journal Leukemia Research (http://www.sciencedirect.com/science/article/pii/S0145212611002505), showed...

Jun 17, 2011, 11:20 ET

Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products

Affineti Biologics has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its research in the...

Jun 14, 2011, 12:45 ET

Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment

Psoriasis is a persistent, long-lasting chronic skin disease affecting 2-3 percent of the world's population or more than 125 million individuals....

Jun 10, 2011, 12:46 ET

Foundation Venture Capital Group President Honored by New Jersey Technology Council

James M. Golubieski, president of New Brunswick-based Foundation Venture Capital Group, LLC, has been honored as a Financier of the Year by the New...

Dec 20, 2010, 11:45 ET

Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract

James M. Golubieski, president of Foundation Venture Capital Group, LLC, (FVCG) a New Jersey Health Foundation affiliate, announced that Snowdon...

Dec 17, 2010, 10:45 ET

Foundation Venture Capital Group Invests in Start-Up Company Working to Improve Mobility for People with Chronic Spinal Cord Injuries

Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options.  In the United States alone, there are more...

Jul 27, 2010, 12:45 ET

Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals

James M. Golubieski, president of Foundation Venture Capital Group, LLC, (FVCG) a New Jersey Health Foundation/Foundation of UMDNJ affiliate,...

May 14, 2010, 09:56 ET

Foundation Venture Capital Group Invests in Start-Up Company Developing Blood Test to Determine Risk and Diagnose Alzheimer's Disease

As many as 5.3 million Americans, and 35 million people worldwide, are living with Alzheimer's disease (AD), a devastating neurodegenerative...

Mar 23, 2009, 10:04 ET

Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments

Each year in the United States more than 138,000 people are diagnosed with leukemia, lymphoma or myeloma. These new cases account for 10 percent...

Nov 24, 2008, 20:07 ET

Foundation Venture Capital Group Invests in Company Working to Protect Healthy Tissue During Cancer Treatment

James M. Golubieski, president of Foundation Venture Capital Group, LLC, a New Jersey Health Foundation affiliate, announced today that the company...

Sep 28, 2007, 01:00 ET

Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics

NEW BRUNSWICK, N.J., Sept. 28 /PRNewswire-USNewswire/ -- James M. Golubieski, president of Foundation Venture Capital Group, LLC, announced...

Mar 21, 2007, 01:00 ET

Foundation Venture Capital Group, LLC Makes First Investment in UMDNJ Research

NEW BRUNSWICK, N.J., March 21 /PRNewswire-USNewswire/ -- Foundation Venture Capital Group, LLC, announced today that it has made a $500,000...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review